leisure time -WSS

leisure time

author：fashion 2025-10-01 23:31:36 - browse：79667

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Creating egg and sperm cells from stem cells raises ethical issues

hotspot

Wikipedia

WSS

Senate panel puts off hardest PBM reforms for another day

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Creating egg and sperm cells from stem cells raises ethical issues

Physicians and social media: If you see something, say something?

Gene editing the human germline: What are the risks?

Why patients can’t get everything they want on drug pricing

leisure time

leisure time

hotspot

How to save PrEP access — and even expand it

Neuroscience’s long legacy of racism

As demand for Covid shots wanes, Moderna seeks its next success

What it's like to live with paralysis for one psychologist

Medicare details structure of new drug price negotiation program

App could help diagnose ear infections more accurately — and at home

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

UnitedHealth increases loan offers after Change Healthcare outage

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Orchard's therapy for neuron disease in children wins FDA approval

hotspot

Creating egg and sperm cells from stem cells raises ethical issues

Nurses recount patients attacks

Orchard's therapy for neuron disease in children wins FDA approval

How doctors’ personal politics affect patients

Truvian presents data for its desktop blood

Baby aspirin cuts fat buildup in liver disease patients, in small study

hotspot

hotspot

Wikipedia

explore